Sweet surprise: dates may improve blood sugar in diabetes trial
NCT ID NCT07467967
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether eating 3 dates daily for 8 weeks can improve blood sugar control and reduce oxidative stress in 130 adults with well-controlled type 2 diabetes. Participants replace a carbohydrate portion with dates to keep calories steady. The goal is to see if this simple dietary change is safe and potentially beneficial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
dates (Deglet Nour variety)
What this could lead to
If it works, this could show that moderate date consumption is safe and may help improve blood sugar control and reduce oxidative stress in type 2 diabetes.
What could go wrong
This is a small, early-stage study with only 130 participants over 8 weeks. Results may not apply to all diabetes patients, and dates are high in sugar, which could raise blood sugar if not carefully substituted.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
La Rabta Hospital , Endocrinology Department
Tunis, 1, Tunisia